专利检索 ap:("CELL GENESYS, INC.") AND inv:"NGUYEN, Minh" 第 1 页

1.

发明公开
TARGETING MULTIPLE ANGIOGENIC PATHWAYS FOR CANCER THERAPY USING SOLUBLE TYROSINE KINASE RECEPTORS 审中-公开
标题翻译：击靶多条路径血管新生用于癌症治疗使用即时酪氨酸激酶

公开(公告)号：EP1877429A2

公开(公告)日：2008-01-16

申请号：EP06749906.1

申请日：2006-04-11

申请人： CELL GENESYS, INC.

发明人： HARDING, Thomas , NGUYEN, Minh

IPC分类号： C07K14/435 , C07K14/705 , C12N5/10 , C12N15/12 , C12N15/62 , C12N15/63

CPC分类号： C07K14/71 , C07K2319/30 , C07K2319/70 , C12N2830/205 , C12N2840/203

摘要： Multivalent soluble receptor proteins that bind to more than one angiogenic factor are described. Nucleotide and vector sequences which encode the multivalent soluble receptor protein, as well as host cells which comprise them and methods of making and using them are also described. The multivalent soluble receptor proteins and vectors which encode them find utility in treatment of cancer and other diseases associated with angiogenesis.

2.

发明公开
METHODS AND COMPOSITIONS FOR IDENTIFYING PROSTATE CANCER OR A HUMORAL IMMUNE RESPONSE AGAINST PROSTATE CANCER 有权
标题翻译：方法和组合物鉴定患者的前列腺癌或预防前列腺癌的体液免疫应答

公开(公告)号：EP2132324A2

公开(公告)日：2009-12-16

申请号：EP08726345.5

申请日：2008-03-03

申请人： Cell Genesys Inc.

发明人： JOOSS, Karin , HARDING, Thomas , NGUYEN, Minh , KOPRIVNIKAR, Kathryn, E.

IPC分类号： C12Q1/00 , G01N33/567 , G01N33/574

CPC分类号： G01N33/57434 , G01N33/6863 , G01N2333/535

摘要： The present invention relates to prostate cancer markers, compositions comprising such markers, immunoglobulins specific for such markers, and methods of using such markers and/or immunoglobulins to assess an immune response against prostate cancer. An immune response against the markers correlates with an immune response, in particular a humoral immune response, against prostate cancer cells which immune response is preferably associated with prophylaxis of prostate cancer, treatment of prostate cancer, and/or amelioration of at least one symptom associated with prostate cancer.